Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC15598 structure
    GC15598Ac2-26
    CAS: 151988-33-9
    纯度: >99.00% / >98.50%

    An annexin A1-mimetic peptide

  • GC15605 structure
    GC15605Ezetimibe
    CAS: 163222-33-1
    纯度: >99.50% / >99.00%

    Ezetimibe是一种选择性胆固醇吸收抑制剂,对肺癌细胞(A549)和人胚肾细胞(HEK293)的IC 50 为50µM,对黑色素瘤细胞(A375)的IC 50 为30µM,作用时间均为48h。

  • GC15714 structure
    GC15714SC 144
    CAS: 895158-95-9
    纯度: >98.50%

    A gp130 inhibitor

  • GC15727 structure
    GC15727Aminoguanidine hydrochloride
    CAS: 1937-19-5
    纯度: >99.00%

    An iNOS inhibitor

  • GC15807 structure
    GC15807L-NIL hydrochloride
    CAS: 159190-45-1;150403-89-7

    L-NIL hydrochloride 是一种诱导型 NO 合酶抑制剂,对 miNOS 的 IC50 为 3.3 μM。

  • GC15811 structure
    GC15811Nigericin sodium salt
    CAS: 28643-80-3
    纯度: >98.00% / >95.00%

    尼杆菌素钠盐是一种来自湿地链霉菌的电中性K+/H+离子载体,它是一种亲脂性抗生素,可以选择性地导致钾从线粒体膜中流失。

  • GC15933 structure
    GC15933Troxerutin
    CAS: 7085-55-4
    纯度: >98.00%

    A flavonoid with diverse biological activities

  • GC15942 structure
    GC15942ML 120B dihydrochloride

    IKK2-selective inhibitor

  • GC15949 structure
    GC15949Benfotiamine
    CAS: 22457-89-2
    纯度: >99.00%

    A lipid-soluble form of vitamin B 1

  • GC15961 structure
    GC15961β-acetyl-Boswellic Acid
    CAS: 5968-70-7

    An anti-inflammatory pentacyclic triterpene

  • GC16007 structure
    GC16007Methylthiouracil
    CAS: 56-04-2
    纯度: >98.00%

    甲基硫氧嘧啶是一种抗甲状腺药物。

  • GC16057 structure
    GC16057MNITMT
    CAS: 177653-76-8

    MNITMT 是一种更有效的免疫抑制剂,没有骨髓毒性。

  • GC16096 structure
    GC16096PR 39 (porcine)
    CAS: 139637-11-9

    PR 39(猪)是一种富含脯氨酸和精氨酸的天然抗菌肽,是一种非竞争性、可逆的变构蛋白酶体抑制剂。

  • GC16155 structure
    GC16155Cefprozil
    CAS: 92665-29-7

    A cephalosporin antibiotic

  • GC16200 structure
    GC16200L-Biopterin
    CAS: 22150-76-1
    纯度: >99.50%

    An intermediate for tetrahydro-L-biopterin

  • GC16220 structure
    GC16220CH 223191
    CAS: 301326-22-7
    纯度: >98.50% / >98.00%

    CH 223191是一种有效且特异性的芳烃受体(AhR)拮抗剂,可抑制TCDD介导的AhR核转位和DNA结合,并抑制TCDD诱导的荧光素酶活性,IC50为0.03 μM。

  • GC16233 structure
    GC16233Tacrolimus (FK506)
    CAS: 104987-11-3
    纯度: >99.90% / >98.00%

    他克莫司 (FK506) 是一种具有强效免疫抑制作用的大环内酯类抗生素,从筑波链霉菌中分离出来,以前曾用于预防人类同种异体移植和治疗自身免疫性疾病。

  • GC16245 structure
    GC16245ATB-343
    CAS: 1000700-26-4

    A H 2 S-releasing NSAID

  • GC16280 structure
    GC16280DMXAA (Vadimezan)
    CAS: 117570-53-3
    纯度: >98.00% / >97.00%

    DMXAA (Vadimezan)是一种选择性的DT-心肌黄酶抑制剂,Ki值为20μM,IC50值为62.5μM。

  • GC16306 structure
    GC16306Dapsone
    CAS: 80-08-0
    纯度: >99.00%

    An anti-inflammatory, antimalarial, and antibacterial compound

  • GC16345 structure
    GC16345Bropirimine
    CAS: 56741-95-8
    纯度: >98.00%

    An immunomodulator with diverse biological activities

  • GC16368 structure
    GC16368Indole-3-carbinol
    CAS: 700-06-1
    纯度: >98.00%

    A natural phytochemical

  • GC16407 structure
    GC16407Imiquimod
    CAS: 99011-02-6
    纯度: >99.00%

    A TLR7 agonist

  • GC16445 structure
    GC16445Pam3CSK4 Biotin
    纯度: >95.00%

    biotinylated Pam3CSK4, a toll-like receptor 1/2 agonist